ONE YEAR ENDOSCOPIC AND HISTOLOGIC OUTCOMES TO TOFACITINIB THERAPY IN REFRACTORY ULCERATIVE COLITIS

被引：0
|
作者：
Verstockt, Bram
Alsoud, Dahham
Outtier, An
Sabino, Joao
Vermeire, Severine
De Hertogh, Gert
Ferrante, Marc
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su462
引用
收藏
页码：S702 / S702
页数：1
相关论文
共 50 条
  • [1] One year endoscopic and histologic outcomes to tofacitinib therapy in refractory ulcerative colitis
    Verstockt, B.
    Aden, K.
    Alsoud, D.
    Outtier, A.
    Sabino, J.
    Rosenstiel, P.
    Vermeire, S.
    De Hertogh, G.
    Schreiber, S.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S456 - S457
  • [2] Real-world clinical and endoscopic outcomes after one year tofacitinib treatment in ulcerative colitis
    Straatmijer, Tessa
    van Gennep, Sara
    Duijvestein, Marjolijn
    Ponsioen, Cyriel I. J.
    Gecse, Krisztina B.
    D'Haens, Geert R.
    Lowenberg, Mark
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (10) : 1288 - 1297
  • [3] Tofacitinib Adherence and Outcomes in Patients With Refractory Ulcerative Colitis
    Wiles, C. Alex
    Shah, Nisha
    Bell, Jacob
    Pabla, Baldeep S.
    Scoville, Elizabeth
    Dalal, Robin
    Beaulieu, Dawn
    Schwartz, David A.
    Horst, Sara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S411 - S411
  • [4] Outcomes of endoscopic and histologic remission in ulcerative colitis under advanced therapy
    Rodrigues, I.
    Bronze, S.
    Fernandes, S.
    Saraiva, S.
    Bernardo, S.
    Goncalves, A. R.
    Moura Santos, P.
    Valente, A.
    Araujo Correia, L.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I601 - I601
  • [5] Clinical and Endoscopic Outcomes Through 78 Weeks of Tofacitinib Therapy for Ulcerative Colitis in a US Cohort
    Dalal, Rahul
    Sharma, Puza
    Bains, Kanwal
    Pruce, Jordan
    Allegretti, Jessica
    INFLAMMATORY BOWEL DISEASES, 2023,
  • [6] Endoscopic and histologic outcome in tofacitinib treated refractory moderate-to-severe ulcerative colitis: A prospective real-life cohort
    Verstockt, B.
    Outtier, A.
    Lefrere, J.
    Sabino, J.
    Vermeire, S.
    De Hertogh, G.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S369 - S370
  • [7] ENDOSCOPIC AND HISTOLOGIC OUTCOME IN TOFACITINIB TREATED REFRACTORY MODERATE-TO-SEVERE ULCERATIVE COLITIS: A PROSPECTIVE REAL-LIFE COHORT
    Verstockt, Bram
    Outtier, An
    Lefrere, Jolien
    Sabino, Joao
    Vermeire, Severine
    De Hertogh, Gert
    Ferrante, Marc
    GASTROENTEROLOGY, 2020, 158 (06) : S952 - S952
  • [8] One-year outcomes with ustekinumab therapy in infliximab-refractory paediatric ulcerative colitis: a multicentre prospective study
    Dhaliwal, Jasbir
    McKay, Hayley E.
    Deslandres, Colette
    Debruyn, Jennifer
    Wine, Eytan
    Wu, Ashley
    Huynh, Hien
    Carman, Nicholas
    Crowley, Eileen
    Church, Peter C.
    Walters, Thomas D.
    Ricciuto, Amanda
    Griffiths, Anne M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (12) : 1300 - 1308
  • [9] Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
    Shimizu, Hiromichi
    Fujii, Toshimitsu
    Hibiya, Shuji
    Motobayashi, Maiko
    Suzuki, Kohei
    Takenaka, Kento
    Saito, Eiko
    Nagahori, Masakazu
    Ohtsuka, Kazuo
    Watanabe, Mamoru
    INTESTINAL RESEARCH, 2021, 19 (01) : 115 - +
  • [10] Endoscopic diagnosis of refractory ulcerative colitis
    Hirata I.
    Murano M.
    Inflammopharmacology, 2007, 15 (1) : 22 - 25
12345